Ginsenoside Rg3 inhibits tumor necrosis factor-α-induced expression of cell adhesion molecules in human endothelial cells

Pharmazie

Volumn 65, Issue 9, 2010, Pages 699-701

  Hien, Tran Thi ^a   Kim, Nak Doo ^b   Kim, Hyung Sik ^c   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

^b Seoul National University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GINSENOSIDE RG 3; INTERCELLULAR CELL ADHESION MOLECULE 1; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINSENOSIDES; HUMANS; INDICATORS AND REAGENTS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957976228     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0569     Document Type: Article

References (21)

1. Apostolakis S, Vogiatzi K, Krambovitis E, Spandidos DA (2008) IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications. Cardiovasc Hematol Agents Med Chem 6: 150-158.
2. Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH (2006a) Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulatedBV-2 microglial cells. Planta Med 72: 627-633.
3. Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH (2006b) Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med 72: 627-633.
4. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9: 899-909.
5. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM (1996) Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 16: 1000-1006.
6. Gillis CN (1997) Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 54: 1-8.
7. Glass CK, Witztum JL (2001) Atherosclerosis: The road ahead. Cell 104: 503-516.
8. Hwang JT, Lee MS, Kim HJ, Sung MJ, Kim HY, Kim MS, Kwon DY (2009) Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res 23: 262-266.
9. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267: 16323-16329.
10. Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI (1999) Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85: 199-207.
11. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK, Surh YJ (2003) Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 523-524: 75-85.
12. Kim JH, Hong YH, Lee JH, Kim DH, Nam G, Jeong SM, Lee BH, Lee SM, Nah SY (2005) A role for the carbohydrate portion of ginsenoside Rg3 in Na+ channel inhibition. Mol Cells 19: 137-142.
13. Kim M, Ahn BY, Lee JS, Chung SS, Lim S, Park SG, Jung HS, Lee HK, Park KS (2009) The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochem Biophys Res Commun 389: 70-73.
14. Kim ND, Kang SY, Kim MJ, Park JH, Schini-Kerth VB (1999) The ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels. Eur J Pharmacol 367: 51-57.
15. Kim ND, Kim EM, KangKW, Cho MK, Choi SY, Kim SG (2003) Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Br J Pharmacol 140: 661-670.
16. Ledebur HC, Parks TP (1995) Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kB site and p65 homodimers. J Biol Chem 270: 933-943.
17. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874.
18. Pober JS, GimbroneMAJr, Lapierre LA, Mendrick DL, FiersW, Rothlein R, Springer TA(1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137: 1893-1896.
19. Price DT, Loscalzo J (1999) Cellular adhesion molecules and atherogenesis. Am J Med 107: 85-97.
20. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
21. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, Dellsperger KC, Zhang C (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116: 219-230.